Drug
Acetylglucosamine clinical trials
- studies test it
- 6
- open now
- 1
- in phase 3
- 2
- first study started
- 2013
Keep track of what changes. Save the Acetylglucosamine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2015 | 2 |
| 2020 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 3
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 5
Third Military Medical University (2) · Quantinosis.ai LLC (1) · Queen Mary University of London (1) · Johns Hopkins University (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Acetylglucosamine is read from its arms, and is right about nine times in ten.
Testing it · 6
- Oral N-acetylglucosamine in Crohn's DiseaseNot yet recruitingPhase 2Johns Hopkins UniversityNCT07225998Written as N-Acetylglucosamine (GlcNAc)
- N-Acetyl Glucosamine as Therapeutic Intervention for Coronavirus Disease-19 (COVID-19)CompletedPhase 1Quantinosis.ai LLCNCT04706416Written as N-acetyl glucosamine (NAG)
- Therapeutic Approaches to Malnutrition EnteropathyCompletedPhase 2Queen Mary University of LondonNCT03716115Written as N-Acetyl Glucosamine (GInNAC)
- Immunologic Effects of Supplemental Monosaccharide and Nucleoside Derivatives in Patients With Inherited Disorders of GlycosylationTerminatedPhase 1National Institute of Allergy and Infectious Diseases (NIAID)NCT02511041Written as N-Acetylglucosamine (GlcNAc)
- Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D TreatmentStatus unknownPhase 2/3Third Military Medical UniversityNCT01893606Written as N-acetyl-D-glucosamine
- Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D TreatmentStatus unknownPhase 3Third Military Medical UniversityNCT02504060Written as N-acetyl-D-glucosamine
Codes
What other systems call Acetylglucosamine · ClinicalTrials.gg INT006897
- MeSH (NLM) D000117AcetylglucosamineOne source NLM
- UNII (FDA) V956696549N-ACETYLGLUCOSAMINEConfirmed FDA, NLM
- RxNorm 1362871One source FDA
- NCI Thesaurus C83975N-AcetylglucosamineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000117 | Acetylglucosamine | One source NLM |
| UNII (FDA) | V956696549 | N-ACETYLGLUCOSAMINE | Confirmed FDA, NLM |
| RxNorm | 1362871 | — | One source FDA |
| NCI Thesaurus | C83975 | N-Acetylglucosamine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.